News from SGC

Posted on Friday 17th of July 2015

Professors Markus Perkmann from Imperial College London and Henri Schildt of Aalto University School of Business report on their findings in the journal Research Policy on managing open data partnerships and the role of boundary organizations such as the SGC. 

Posted on Thursday 16th of July 2015

 WD Repeat domain 5 (WDR5) is a critical part of the human trithorax/COMPASS complexes which are responsible for methylation of lysine 4 on histone 3 (H3K4) via one of several catalytic subunits, Mixed-Lineage Leukemia (MLL), MLL2, MLL3, or MLL4 proteins.

Posted on Friday 10th of July 2015

Posted on Thursday 18th of June 2015
Posted on Friday 12th of June 2015

In their most recent issue of Show me the Evidence, the Canadian Institutes for Health Research (CIHR) included a feature piece on SGG's research in an interview with SGC-Toronto's Chief Scientist, Dr Cheryl Arrowsmith.

Posted on Monday 25th of May 2015

Toronto, Canada, May 25, 2015. 

Posted on Wednesday 13th of May 2015

Recent article on Nature Biotechnology highlights SGC’s new open access initiative to use human cell for target validation.

Posted on Wednesday 13th of May 2015

Chas Bountra, SGC Oxford’s Chief Scientist and Professor of Translational Medicine at the University of Oxford, is a guest on Will Gompertz’s BBC radio show to discuss how SGC and Oxford scientists are contributing to the development of new and affordable medicines for diseases such as dementia.

Posted on Friday 17th of April 2015

Toronto, ON (April 17th, 2015) - The Structural Genomics Consortium (SGC) at the University of Toronto and the Ontario Brain Institute (OBI) have entered into an “open-source” research partnership with two Toronto-based hospitals to test tool compounds, called chemical probes, against epigenetic proteins in research models of Rett syndrome.


Subscribe to News from SGC
glqxz9283 sfy39587stf02 mnesdcuix8